Genesis IBRC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194N01016
  • NSEID:
  • BSEID: 514336
INR
93.70
4.45 (4.99%)
BSENSE

Dec 22

BSE+NSE Vol: 563

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGenesis IBRC VS Pharmaceuticals & Biotechnology
 
1D
4.99%
0.75%
1W
8.76%
0.42%
1M
-40.81%
0.39%
YTD
%
9.51%
1Y
%
9.64%
3Y
775.7%
40.68%
5Y
1156.03%
85.99%
10Y
504.52%
234.37%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
51.37%
0%
51.37%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
863.0%
0%
863.0%
3 Years
775.7%
0%
775.7%
4 Years
1095.15%
0%
1095.15%
5 Years
1156.03%
0%
1156.03%

Genesis IBRC for the last several years.

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available